Alphatec (US:ATEC)2025-05-01 20:19Financial Performance - Surgical revenue reached $152 million, a 24% increase[5] - Total revenue was $169 million, representing a 22% growth[5] - Adjusted EBITDA was $11 million, an increase of $14 million year-over-year[8] - Adjusted EBITDA as a percentage of sales improved by 840 basis points to 6%[8] - The company reduced Q1 free cash use by $55 million year-over-year[11] Outlook - The company anticipates surgical revenue of $658 million, a 21% increase for 2025[16] - EOS revenue is projected to be $76 million, a 13% increase for 2025[16] - Total revenue for 2025 is expected to be $734 million, a 20% increase[16] - The company is on track to deliver positive free cash flow for the full year 2025[3] Balance Sheet - Cash reserves stand at $153 million[11] - Available borrowing capacity is $60 million, resulting in total cash and available cash of $213 million[11]